Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Permanent Phage Infections

Objective

The antimicrobial resistance crisis is escalating, and while phage therapy can clear acute infections, eradication of chronic infections reThe antimicrobial resistance crisis is escalating, and while phage therapy can clear acute infections, eradication of chronic infections remains elusive. This limitation is attributed to host physiology under stress that limits phage replication. But the prevailing assumption that virulent phages inevitably proceed to lysis is increasingly challenged. Our recent findings show that nucleus-forming phages can replicate in synchrony with their host across generations without lysis—a phenomenon we summarize as permanent phage replication cycle. This replication strategy is invisible to classical plaque assays, mechanistically unexplored, and may explain why chronic infections resist clearance.

Hypothesis. Nucleus-forming phages use their specialised compartments together with host-takeover factors to establish and maintain permanent replication under stress. If we can define, measure, and disrupt this cycle, we can convert persistence into clearance.

Aims. Define and quantify permanent replication cycles. Map the molecular landscape of permanency. Identify and characterize key determinants, and engineer phages that bypass permanency to generate hyper-virulent phages.

Approach. We combine quantitative virology, utilise time-resolved single-cell assays and fluorescence imaging and electron microscopy in a validated E. coli–Goslarvirus model that demonstrates both technical feasibility and a clear knowledge gap.

Impact. The project will (i) deliver the first mechanistic framework for the permanent phage replication cycle, (ii) establish tools and criteria to detect permanency, guiding the discovery of novel phages, and (iii) provide a rational framework for designing therapeutic phages that skip permanency—enabling faster clearance. This work reframes virulent phage biology and lays the foundation for next-generation phage therapy.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2026-STG

See all projects funded under this call

Host institution

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Net EU contribution
€ 1 499 982,00
Address
INHOFFENSTRASSE 7
38124 Braunschweig
Germany
Region
Niedersachsen Braunschweig Braunschweig, Kreisfreie Stadt
Activity type
Research Organisations
Links
Total cost
€ 1 499 982,00

Beneficiaries (1)